Group B characteristics
| Characteristic . | Responders (n = 9) . | Nonresponders (n = 10) . |
|---|---|---|
| Cytogenetic/molecular features | ||
| Normal | 1 | 0 |
| Favorable inv(16), t(8;21) | 2 | 0 |
| 11q23 | 2 | 0 |
| Del5q/monosomy 5 | 1 | 1 |
| Monosomy 7 | 1 | 2 |
| FLT3-ITD | 0 | 2 |
| NUP98-NSD1 | 1 | 0 |
| DEK-NUP214 | 1 | 0 |
| ETV6 rearrangement | 0 | 2 |
| Other | 0 | 3 |
| Prior HSCT | ||
| No | 5 (55.5%) | 9 (90%) |
| Yes | 4 (44.4%) | 1 (10%) |
| Characteristic . | Responders (n = 9) . | Nonresponders (n = 10) . |
|---|---|---|
| Cytogenetic/molecular features | ||
| Normal | 1 | 0 |
| Favorable inv(16), t(8;21) | 2 | 0 |
| 11q23 | 2 | 0 |
| Del5q/monosomy 5 | 1 | 1 |
| Monosomy 7 | 1 | 2 |
| FLT3-ITD | 0 | 2 |
| NUP98-NSD1 | 1 | 0 |
| DEK-NUP214 | 1 | 0 |
| ETV6 rearrangement | 0 | 2 |
| Other | 0 | 3 |
| Prior HSCT | ||
| No | 5 (55.5%) | 9 (90%) |
| Yes | 4 (44.4%) | 1 (10%) |